Vcanbio Cell & Gene Engineering Corp. Ltd. provided earnings guidance for the year 2017. For the year, the company predicts that it will suffer a loss in its net profit owned by shareholders of the listed company for 2017, compared with that at the same period of the year before (based on the disclosed statistics according to relevant regulations), with the net loss owned by shareholders of the listed company to be about RMB 18 million. The net loss belonging to shareholders of the listed company after excluding extraordinary profit and loss will be about RMB 17 million.